Trademark: 79280943
Word
NGALDS
Status
Dead
Status Code
404
Status Date
Wednesday, July 7, 2021
Serial Number
79280943
Registration Number
6358230
Registration Date
Tuesday, May 25, 2021
Mark Type
5000
Filing Date
Monday, October 28, 2019
Published for Opposition
Tuesday, March 9, 2021
Cancellation Date
Wednesday, July 7, 2021

Trademark Owner History
BioPorto Diagnostics A-S - Original Registrant

Classifications
1 Chemicals used in industry and science; stem cells for research and scientific purposes; biochemical, namely, monoclonal antibodies for in vitro diagnostic scientific or industrial research; cells for scientific and research use, namely, DNA and RNA preparations for scientific and industrial purposes; proteins for use within science, namely, protein in raw material form for scientific research, protein assays for scientific research; diagnostic kits consisting primarily of monoclonal stem cells, antibodies and proteins for scientific research, in vitro diagnostic tests and disease testing; chemical reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; diagnostic test materials, namely, comprising diagnostic reagents, for scientific purposes, not for medical or veterinary purposes; assays for research purposes
5 Pharmaceutical and veterinary preparations for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; biological materials, namely, stem cells for medical and veterinary purposes; biological preparations for medical and veterinary purposes, specifically, for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; diagnostic kits and drug testing kits consisting primarily of stem cells, antibodies and proteins for medical and veterinary purposes for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; reagents for medical diagnosis and/or analysis; clinical medical reagents; diagnostic preparations for medical purposes; diagnostic test materials, namely, comprising diagnostic agents, preparations and substances for medical use; diagnostic kits comprising primarily diagnostic agents, preparations and substances for medical use; biological materials, namely, monoclonal antibodies for use in medical research, namely, in vitro diagnostic tests and disease testing
Color is not claimed as a feature of the mark.
NGAL DS

Trademark Events
Jul 23, 2021
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jul 23, 2021
Death Of International Registration
Jul 17, 2021
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jul 17, 2021
Death Of International Registration
Jul 12, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2021
Teas Change Of Correspondence Received
Jul 12, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 12, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 12, 2021
Teas Change Of Owner Address Received
May 25, 2021
Registered-Principal Register
Mar 9, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 9, 2021
Published For Opposition
Mar 7, 2021
Notification Processed By Ib
Feb 17, 2021
Notification Of Possible Opposition Sent To Ib
Feb 17, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 17, 2021
Notification Of Notice Of Publication E-Mailed
Jan 28, 2021
Approved For Pub - Principal Register
Jan 14, 2021
Teas/Email Correspondence Entered
Jan 14, 2021
Correspondence Received In Law Office
Jan 7, 2021
Assigned To Lie
Sep 28, 2020
Teas Response To Office Action Received
Apr 18, 2020
Refusal Processed By Ib
Apr 1, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Apr 1, 2020
Refusal Processed By Mpu
Mar 21, 2020
Application Filing Receipt Mailed
Mar 18, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Mar 17, 2020
Non-Final Action Written
Mar 17, 2020
Assigned To Examiner
Mar 17, 2020
New Application Office Supplied Data Entered In Tram
Mar 12, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24